U.S. Physical Therapy, Inc. (USPH)

U.S. Physical Therapy Stock Forecast

Stock Price Forecast

The 4 analysts that cover U.S. Physical Therapy stock have a consensus rating of "Strong Buy" and an average price target of $109, which forecasts a 47.72% increase in the stock price over the next year. The lowest target is $98 and the highest is $115.

Price Target: $109 (+47.72%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$98	$109	$113	$115
Change	+32.81%	+47.72%	+53.14%	+55.85%

* Price targets were last updated on Apr 22, 2025.

Analyst Ratings

The average analyst rating for U.S. Physical Therapy stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	1	1	1	1	1	1
Buy	3	3	3	3	3	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Constantine Davides JMP Securities	JMP Securities	Buy Reiterates $113	Buy	Reiterates	$113	+53.14%	Apr 22, 2025
Calvin Sternick JP Morgan	JP Morgan	Buy Maintains $120 → $110	Buy	Maintains	$120 → $110	+49.07%	Mar 19, 2025
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $108 → $98	Buy	Maintains	$108 → $98	+32.81%	Feb 28, 2025
Joanna Gajuk B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $100 → $115	Hold → Strong Buy	Upgrades	$100 → $115	+55.85%	Dec 16, 2024
Constantine Davides JMP Securities	JMP Securities	Buy Initiates $113	Buy	Initiates	$113	+53.14%	Dec 16, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

775.23M

Increased by 16.68%

from 664.43M

Revenue Next Year

822.12M

Increased by 6.05%

from 775.23M

EPS This Year

2.61

Increased by 42.05%

from 1.84

EPS Next Year

2.88

Increased by 10.14%

from 2.61

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	418.35M	489.72M	547.60M	598.63M	664.43M	775.23M	822.12M	890.68M
Revenue Growth	-12.32%	17.06%	11.82%	9.32%	10.99%	16.68%	6.05%	8.34%
EPS	2.48	2.41	2.25	1.28	1.84	2.61	2.88	3.16
EPS Growth	1.06%	-2.66%	-6.49%	-43.27%	43.97%	42.05%	10.14%	9.80%
Forward PE	-	-	-	-	-	28.22	25.62	23.34
No. Analysts	-	-	-	-	-	9	9	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	814.0M	877.5M	944.4M
Avg	775.2M	822.1M	890.7M
Low	730.5M	772.9M	830.1M

Revenue Growth

Revenue Growth	2025	2026	2027
High	22.5%	13.2%	14.9%
Avg	16.7%	6.0%	8.3%
Low	9.9%	-0.3%	1.0%

EPS Forecast

EPS	2025	2026	2027
High	3.02	3.20	3.26
Avg	2.61	2.88	3.16
Low	2.29	2.35	3.04

EPS Growth

EPS Growth	2025	2026	2027
High	64.3%	22.5%	13.0%
Avg	42.0%	10.1%	9.8%
Low	24.6%	-10.0%	5.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.